Wistar scientists identify a gene signature to assess cancer risk in people.

Keywords: Cancer; Cancer Risk; Drugs and Therapies; Genetics; Health and Medicine; Oncology; Personalized Medicine; Personalized Therapy; Risk and Prevention; The Wistar Institute EN Cancer Cancer Risk Drugs and Therapies Genetics Health and Medicine Oncology Personalized Medicine Personalized Therapy Risk and Prevention The Wistar Institute 2023 FEB 20 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- PHILADELPHIA - (FEBRUARY, 6, 2023) - In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and Program Leader in the Molecular & Cellular Oncogenesis Program, and team have identified a gene signature that accurately predicts the functioning of P53 variants, important information to assessing cancer risk and optimizing choices for cancer therapeutics. Cancer, Drugs and Therapies, Genetics, Health and Medicine, Oncology, Personalized Medicine, Personalized Therapy, Risk and Prevention, The Wistar Institute, Cancer Risk. [Extracted from the article]